Liver-selective glucokinase activator PFE-GKA-2 shows improved hypoglycemic control in vivo April 6, 2011
Final SELECT-2 data show CR2b is efficacious against hepatitis C when dosed every 2 weeks April 5, 2011
Antitumor effects of tolfenamic acid correlate with downregulation of transcription factors Sp1/3/4 April 5, 2011
RSS